Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Clinical trial NCT00406211 · COMPLETED

Trial details

NCT number: NCT00406211
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rubella Varicella Mumps Measles

Start date: 2004-07-01
Primary completion: 2004-12-01
Enrollment: 398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.